| SATURDAY APRIL 26, 2008 |
| 09:00 |
REGISTRATION OPENS |
| 11:00-12:00 |
COMPANY SPONSORED SYMPOSIUM |
| 11:00-12:00 |
COMPANY SPONSORED SYMPOSIUM |
| 12:30-13:00 |
Break |
| 13:00-14:30 |
COMPANY SPONSORED SYMPOSIUM |
| 14:30-15:00 |
Break |
| 15:00-16:30 |
ASTRA ZENECA COMPANY SPONSORED SYMPOSIUM
NEW IN SIGHTS INTO ATHEROSCLEROSIS AND CARDIOVASCULAR RISK
MANAGEMENT |
| 18:00 |
Auditorium (Anitschkow Hall) |
| OPENING CEREMONY |
CONGRESS CHAIRPERSON
L. Tokgözoglu, Turkey |
EAS PRESIDENT
M-R. Taskinen, Finland |
IAS PRESIDENT
J-C. Fruchart, France |
TURKISH CARDIOLOGY ASSOCIATION PRESIDENT
Ç.Erol, Turkey |
MINISTER OF HEALTH
R. Akdağ, Turkey |
KEY-NOTE LECTURE
A. Gotto, USA |
| WELCOME RECEPTION |
| |
| SUNDAY APRIL 27, 2008 |
| 08:30-10:30 |
Auditorium (Anitschkow Hall) |
| ATHEROGENESIS: FROM CELLULAR DYSFUNCTIONS TO THE VULNERABLE PLAQUE |
| Chairs: |
P. Kovenen, Finland
J. Chapman, France |
FROM INITIATION OF ATHEROSCLEROSIS TO PROGRESSION AND CLINICAL
CATASTROPHY
R. Virmani, USA |
IS ATHEROSCLEROSIS AN IMMUNE DISEASE?
Z. Mallat, France |
MOLECULAR REGULATION OF CHOLESTEROL HOMEOSTASIS
A. Tall, USA |
DRUGS AFFECTING PLAQUE INFLAMMATION AND STABILITY
A. C. Newby, UK |
| 10:30-11:30 |
Coffee Break, Exhibition and Poster Viewing |
| 11:30-13:00 |
Auditorium (Anitschkow Hall) |
| Workshop |
| INFLAMMATION IN THE ARTERIAL WALL AND DEVELOPMENT OF CVD |
| Chairs: |
A. Chawla, USA
G. Pasterkamp, The Netherlands |
CONTROL OF MACROPHAGE ACTIVATION BY NUCLEAR RECEPTORS
A. Chawla, USA |
TBA
G. Pasterkamp, The Netherlands |
EFFECT OF APOB-100-DERIVED PEPTIDES ON THE PROLIFERATION AND FUNCTIONAL
PROPERTIES OF REGULATORY T CELLS
C. Pierides, UK |
HYPERLIPIDEMIA ENHANCES LEUKOCYTE ROLLING IN VIVO BY INVOLVING MYD88-
DEPENDENT INNATE IMMUNE PATHWAYS
A. Pistea, Sweden |
EXAMINATION OF THE 5-LIPOXYGENASE/LEUKOTRIENE PATHWAY IN ADVANCED
ATHEROSCLEROTIC LESION AND ABDOMINAL AORTIC ANEURYSM DEVELOPMENT IN
5-LIPOXYGENASE/APOE DEFICIENT MICE
C. Funk, Canada |
HISTAMINE H1 RECEPTOR IS REQUIRED FOR ATHEROGENESIS
I. Rozenberg, Switzerland |
| 13:00-14:00 |
Lunch Break, Exhibition and Poster Viewing |
| 11:30-13:00 |
Marmara (Michael Davies) |
| Workshop |
| INFLAMMATION IN THE ARTERIAL WALL AND DEVELOPMENT OF CVD |
| Chairs: |
A. Chawla, USA
G. Pasterkamp, The Netherlands |
CONTROL OF MACROPHAGE ACTIVATION BY NUCLEAR RECEPTORS
A. Chawla, USA |
TBA
G. Pasterkamp, The Netherlands |
EFFECT OF APOB-100-DERIVED PEPTIDES ON THE PROLIFERATION AND FUNCTIONAL
PROPERTIES OF REGULATORY T CELLS
C. Pierides, UK |
HYPERLIPIDEMIA ENHANCES LEUKOCYTE ROLLING IN VIVO BY INVOLVING MYD88-
DEPENDENT INNATE IMMUNE PATHWAYS
A. Pistea, Sweden |
EXAMINATION OF THE 5-LIPOXYGENASE/LEUKOTRIENE PATHWAY IN ADVANCED
ATHEROSCLEROTIC LESION AND ABDOMINAL AORTIC ANEURYSM DEVELOPMENT IN
5-LIPOXYGENASE/APOE DEFICIENT MICE
C. Funk, Canada |
HISTAMINE H1 RECEPTOR IS REQUIRED FOR ATHEROGENESIS
I. Rozenberg, Switzerland |
| 13:00-14:00 |
Lunch Break, Exhibition and Poster Viewing |
| 11:30-13:00 |
Marmara (Michael Davies) |
| Workshop |
| MECHANISM FOR VASCULAR PROTECTION BY HDL |
| Chairs: |
J- R. Nofer, Germany
A. von Eckardstein, Switzerland |
PLEIOTROPIC ATHEROPROTECTIVE EFFECTS OF HDL
J- R. Nofer, Germany |
TBA
A. von Eckardstein, Switzerland |
| APOLIPOPROTEIN M IS BOUND TO LIPOPROTEINS VIA ITS RETAINED SIGNAL PEPTIDE
J. Ahnstrom, Sweden |
ALPHA 1-ANTITRYPSIN ASSOCIATED WITH HDL INHIBITS ANOIKIS OF VASCULAR
CELLS: A NEW ANTI-ATHEROGENIC PROPERTY FOR HDL
O.Meilhac, France |
RVX-208: A SMALL MOLECULE THAT INCREASES APOA-I, HDL-C, AND CHOLESTEROL
EFFLUX
N. Wong, Canada |
EFFECT OF EXPERIMENTAL HYPERLEPTINEMIA ON PLASMA PARAOXONASE 1 (PON1)
ACTIVITY TOWARD HOMOCYSTEINE THIOLACTONE AND N-HOMOCYSTEINYLATION
OF PLASMA PROTEINS
J. Beltowski, Poland |
| 13:00-14:00 |
Lunch Break, Exhibition and Poster Viewing |
| 11:30-13:00 |
Topkapi (Remzi Özcan) |
| Workshop |
| THROMBOGENIC RISK FACTORS FOR ATHEROTHROMBOSIS |
| Chairs: |
R. De Caterina, Italy
P.J.Grant, UK |
TBA
R. De Caterina, Italy |
TBA
P.J.Grant, UK |
RED BLOOD CELL DERIVED MICROPARTICLES ARE THROMBOGENIC IN VITRO AND
IN MOUSE MODELS OF ATHEROSCLEROSIS IN VIVO
H. Isobe, Austria |
ASPIRIN RESISTANCE IS A RISK FACTOR FOR NON-FATAL CORONARY EVENTS AFTER
PERCUTANEOUS CORONARY INTERVENTIONS
A.B. Catakoglu, Turkey |
PRESENCE OF TYPE 2 DIABETES SIGNIFICANTLY MODULATES THE CARDIOVASCULAR
RISK CONFERRED BY THE PLASMINOGEN ACTIVATOR INHIBITOR-1 -675 5G/4G
POLYMORPHISM
C.H. Saely, Austria |
THE PROTHROMBOTIC PHENOTYPE OBSERVED IN NIDDM IS INDEPENDENT OF BLOOD
GLUCOSE LEVELS
L. Badimon, Spain |
| 13:00-14:00 |
Lunch Break, Exhibition and Poster Viewing |
| 11:30-13:00 |
Haliç (Nikkila) |
| Workshop |
| CELL THERAPIES FOR ISCHAEMIC TISSUES AND PRECONDITIONING |
| Chairs: |
H. Drexler, Germany
D. Hausenloy, UK |
TBA
H. Drexler, Germany |
FROM ISCHAEMIC PRECONDITIONING TO POSTCONDITIONING: NEW FRONTIERS IN
CARDIOPROTECTION
D. Hausenloy, UK |
REPERFUSION INDUCES FAS (CD95) ACTIVATION IN CARDIOMYOCYTES IN A PIG
MODEL OF ISCHAEMIC -REPERFUSION
G. Vilahur, Spain |
INFLUENCE OF REGENERATION ON MOBILIZATION OF BM-CPC BY INTRACORONARY
AUTOLOGOUS BM-CELL TRANSPLANTATION IN PATIENTS WITH AMI AND CHRONIC
MI
R.G.Turan, Germany |
THE NUMBER OF CIRCULATING ENDOTHELIAL PROGENITOR CELLS INCREASES
WITH INCREASING SEVERITY OF CHRONIC PERIPHERAL ARTERIAL OCCLUSIVE
DISEASE
N. Weiss, Germany |
ENDOTHELIAL CELLS ARE ACTIVATED DURING HYPOXIA VIA ENDOGLIN/ALK-
1/SMAD1/5 SIGNALING IN VIVO AND IN VITRO
F. Tian, Sweden |
| 13:00-14:00 |
Lunch Break, Exhibition and Poster Viewing |
| 14:00-15:00 |
Auditorium (Anitschkow Hall) |
| JOINT ICCR/EAS WORKSHOP |
| Chairs: |
L. Tokgözoglu, Turkey
L. van Gaal |
OPENING REMARKS
L. Tokgözoglu, Turkey |
THE PLACE OF HDL-C IN GLOBAL CARDIOMETABOLIC RISK
B.Brewer, USA |
THE ATHEROGENIC DYSLIPIDEMIA OF ABDOMINAL OBESITY, INSULIN RESISTANCE
AND GLOBAL CARDIOMETABOLIC RISK
M.R. Taskinen, Finland |
LIFESTYLE OF ABDOMINAL OBESITY AND RELATED CARDIOMETABOLIC RISK; THE
SYNERGIE TRIAL
J.P. Després, Canada |
CLOSING REMARKS
L. van Gaal, Belgium |
| 15:00-15:45 |
Coffee Break, Exhibition and Poster Viewing |
| 14:00-15:00 |
Marmara (Michael Davies) |
| Debate |
| CAN IMAGING STUDIES SUBSTITUTE FOR ENDPOINT STUDIES? |
| Chairs: |
A. Catapano, Italy
A. Oto, Turkey |
CON
J.J. Badimon, USA |
PRO
J.Kastelein, The Netherlands |
| 15:00-15:45 |
Coffee Break, Exhibition and Poster Viewing |
| 14:00-15:00 |
Haliç (Nikkila) |
| How to session |
| HOW TO OPTIMIZE LIPID MANAGEMENT FOR MIXED AND REFRACTORY
DYSLIPIDEMIA |
| Chairs: |
V. Sansoy, Turkey
E. Stein, USA |
| 15:00-15:45 |
Coffee Break, Exhibition and Poster Viewing |
| 14:00-15:00 |
Dolmabahçe (Overflow Eisenberg Hall) |
| POSTER FINALISTS |
| Chairs: |
A. Stalenhoef, The Netherlands
J. Westerbacka, Finland |
| 10 x 5 min Oral presentations selected for the shortlisted abstracts |
| 15:00-15:45 |
Coffee Break, Exhibition and Poster Viewing |
| 15:45-17:15 |
Auditorium (Anitschkow Hall) |
| JOINT EASD/EAS WORKSHOP |
| Chairs: |
U. Beisiegel, Germany
EASD Representative TBA |
| 17:15-17:30 |
Break |
| 15:45-17:15 |
Marmara (Michael Davies) |
| Workshop |
| VULNERABLE PLAQUE. PATHOPHYSIOLOGY AND MECHANISMS OF
ATHEROTHROMBOSIS |
| Chairs: |
M. Bennett, UK
E. Falk, Denmark |
DEATH AND SENESCENCE ARE DIRECT REGULATORS OF PLAQUE VULNERABILITY
M. Bennett, UK |
TBA
E. Falk, Denmark |
EXPRESSION OF CB1 AND CB2 IN HUMAN ATHEROSCLEROTIC PLAQUES
A. Mezzetti, Italy |
NATURAL HISTORY OF CAROTID ATHEROSCLEROTIC PLAQUE REMODELING AFTER
TIA OR STROKE
W. Peeters, The Netherlands |
MONOCYTE-PLATELET AGGREGATES AND MICROPARTICLE FORMATION ARE
REDUCED AFTER CAROTID STENTING
S. Steiner, Austria |
UP- AND DOWNSTREAM STRUCTURAL DIFFERENCES IN CAROTID PLAQUE
COMPOSITION - IMPLICATIONS FOR STUDIES OF HUMAN SYMPTOMATIC CAROTID
PLAQUES
F. Olson, Sweden |
| 17:15-17:30 |
Break |
| 15:45-17:15 |
Topkapi (Remzi Özcan) |
| SCREENING FOR CARDIOVASCULAR RISK:TO WHOM, WHAT AND WHEN? |
| Chairs: |
G. Assmann, Germany
D. Wood, UK |
TBA
G. Assmann, Germany |
THE STATUS OF PREVENTIVE CARDIOLOGY PRACTICE - EUROASPIRE III
D. Wood, UK |
PROSPECTIVE EVALUATION OF CORONARY ARTERY CALCIUM IN PREDICTING
CARDIOVASCULAR EVENTS IN ASYMPTOMATIC PATIENTS WITH TYPE 2 DIABETES:
THE PREDICT STUDY
I. Godsland, UK |
EFFECTS OF 5-YEAR FENOFIBRATE TREATMENT ON ARTERIAL STIFFNESS AND
CAROTID INTIMA-MEDIA THICKNESS IN TYPE 2 DIABETES: FIELD HELSINKI
SUBSTUDY
J. Westerbacka, Finland |
ASSOCIATION BETWEEN SERUM GAMMA-GLUTAMYLTRANSFERASE LEVELS AND
CORONARY MICROVASCULAR FUNCTION
O. Ciftci, Turkey |
SEX DIFFERENCES IN PERIPHERAL ARTERY INTIMA, MEDIA AND INTIMA MEDIA
THICKNESS IN CHILDREN AND ADOLESCENTS
W. Osika, Sweden |
| 17:15-17:30 |
Break |
| 15:45-17:15 |
Haliç (Nikkila) |
| Workshop |
| TRANSCRIPTION FACTORS AND GENETIC DETERMINANTS OF LIPID METABOLISM |
| Chairs: |
G. Chinetti, France
S. Kathiresan, USA |
TBA
G. Chinetti, France |
DEFINING THE INHERITED BASIS FOR COMPLEX TRAITS: BLOOD LIPIDS AND
MYOCARDIAL INFARCTION
S. Kathiresan, USA |
OSBP-RELATED PROTEIN 10 (OSBPL10/ORP10), A NOVEL REGULATOR OF LIPID
HOMEOSTASIS
V. Olkkonen, Finland |
GENETICS OF LOW HDL IN TURKISH CORONARY ARTERY DISEASE PATIENTS
E. Tulumen, Turkey |
ANGPTL4 VARIANTS ARE ASSOCIATED WITH LOWER PLASMA TRIGLYCERIDE LEVELS
AND IMPROVED POSTPRANDIAL RESPONSES
P. Talmud, UK |
INTESTINAL APOLIPOPROTEIN A5 EXPRESSION INVERSELY CORRELATES WITH THAT
OF GENES NEEDED IN LIPOPROTEIN ASSEMBLY (MTP & APOB)
M. Guardiola, Spain |
| 17:15-17:30 |
Break |
| 17:30-19:00 |
MERCK SHARP & DOHME SPONSORED SYMPOSIUM
ER NIACIN/LAROPIPRANT: A NEW PARADIGM IN COMPREHENSIVE LIPID
MANAGEMENT |
| 17:30-19:00 |
COMPANY SPONSORED SYMPOSIUM |
| 19:30 |
YOUNG SCIENTIST’S NIGHT |
| |
| MONDAY APRIL 28, 2008 |
| 08:30-10:30 |
Auditorium (Anitschkow Hall) |
| DETECTION OF ATHEROSCLEROSIS AND VASCULAR DISEASE |
| Chairs: |
M. Averna, Italy
R. Carmena, Spain |
IMPLEMENTING NEW GUIDELINES INTO CLINICAL PRACTICE
I. M Graham, Ireland |
DETECTION OF ATHEROSCLEROSIS: TRENDS FOR THE FUTURE
V. Fuster, USA |
GOING TO EXTREMES TO PREVENT CORONARY HEART DISEASE
J. Cohen, USA |
CELLULAR AND MOLECULAR MARKERS FOR VULNERABLE PLAQUES
M.J.A.P. Daemen, The Netherlands |
| 10:30-11:30 |
Coffee Break, Exhibition and Poster Viewing |
| 11:30-13:00 |
Auditorium (Anitschkow Hall) |
| JOINT ESC/EAS WORKSHOP |
| Chairs: |
M-R. Taskinen, Finland
P. Widimsky, Czech Republic |
RISK PREDICTION IN CLINICAL PRACTICE-TOOLS AND PRINCIPLES
L. Erhardt, Sweden |
LIFE TIME RISK VERSUS 10 YEAR RISK
J. Deanfield, UK |
CARDIOVASCULAR RISK IN WOMEN: IS IT DIFFERENT?
B. Howard, USA |
PRACTICAL APPLICATION OF RISK PREDICTION IN PRIMARY CARE
R. Hobbs, UK |
| 13:00-14:00 |
Lunch Break, Exhibition and Poster Viewing |
| 11:30-13:00 |
Marmara (Michael Davies) |
| Workshop |
| TRENDS IN VASCULAR DISEASE |
| Chairs: |
H. Kültürsay, Turkey
T. R. Pedersen, Norway |
TBA
H. Kültürsay, Turkey |
TBA
T. R. Pedersen, Norway |
INTENSIVE ATORVASTATIN THERAPY REDUCES RISK OF CARDIOVASCULAR EVENTS
BEYOND THE FIRST EVENT IN PATIENTS WITH MULTIPLE EVENTS
M. J. Tikkanen, Finland |
IMPAIRED GLUCOSE TOLERANCE SIGNIFICANTLY INCREASES THE RISK FOR
CARDIOVASCULAR EVENTS IN PATIENTS UNDERGOING ELECTIVE CORONARY
ANGIOGRAPHY
H. Sourij, Austria |
INTENSIVE LIPID LOWERING WITH ATORVASTATIN IS ASSOCIATED WITH
SIGNIFICANT CARDIOVASCULAR BENEFITS IN CORONARY PATIENTS WITH DIABETES
AND CHRONIC KIDNEY DISEASE
J. Shepherd, UK |
TRENDS IN ISCHEMIC HEART DISEASE MORTALITY IN POST COMMUNIST COUNTRIES
USING THE CZECH POPULATION AS AN EXAMPLE
R. Poledne, Czech Republic |
| 13:00-14:00 |
Lunch Break, Exhibition and Poster Viewing |
| 11:30-13:00 |
Topkapi (Remzi Özcan) |
| Workshop |
| VASCULAR ENDOTHELIUM AND MACROPHAGES IN ATHEROGENESIS |
| Chairs: |
S. Lehoux, France
J. Waltenberger, The Netherlands |
TBA
S. Lehoux, France |
DETECTION OF VASCULAR CELL DYSFUNCTION USING PERIPHERAL BLOOD.
MECHANISMS REGULATING ENDOTHELIAL AND MONOCYTE FUNCTION
J. Waltenberger, The Netherlands |
MACROPHAGE APOPTOSIS EXERTS DIVERGENT EFFECTS ON ATHEROGENESIS AS A
FUNCTION OF LESION STAGE AND EFFICIENCY OF APOPTOTIC CELL CLEARANCE
P. Lesnik, France |
TGF-BETA INDUCES ATHEROSCLEROTIC PROGRAM IN MATURE HUMAN
MACROPHAGES
A. Gratchev, Germany |
N-MYC DOWNSTREAM-REGULATED PROTEIN 2 MODULATES PDGF-AA PRODUCTION
IN MACROPHAGE FOAM CELLS VIA INHIBITION ON ACTIVATION OF
EXTRACELLULAR SIGNAL-REGULATED KINASE
P-Y. Yang, China |
BLOCKADE OF THE ANGIOTENSIN TYPE 2 (AT2) RECEPTOR DECREASES DIABETESASSOCIATED
ATHEROSCLEROSIS
T. Allen, Australia |
| 13:00-14:00 |
Lunch Break, Exhibition and Poster Viewing |
| 11:30-13:00 |
Haliç (Nikkila) |
| Workshop |
| GENETIC AND BIOLOGIC BIOMARKERS FOR CHD RISK DETERMINATION |
| Chairs: |
S. Blankenberg, Germany
S. Humphries, UK |
TBA
S. Blankenberg, Germany |
GENETIC MARKERS IMPROVE RISK STRATIFICATION FOR CORONARY HEART
DISEASE
S. Humphries, UK |
CRITICAL APPRAISAL OF THE UTILITY OF CRP MEASUREMENT IN THE PREDICTION
OF CARDIOVASCULAR EVENTS
T. Shah, UK |
EXTREME LIPOPROTEIN(A) LEVELS AND RISK OF MYOCARDIAL INFARCTION IN THE
GENERAL POPULATION - THE COPENHAGEN CITY HEART STUDY
P.R. Kamstrup, Denmark |
INCREASED PLASMA APOLIPOPROTEIN C-III CONCENTRATION PREDICTS
CARDIOVASCULAR MORTALITY: THE HOORN STUDY
P.G. Scheffer, The Netherlands |
SMALL DENSE LDL CHOLESTEROL, HDL PARTICLES, INSULIN, ADIPONECTIN, AND
GLYCATED ALBUMIN AS PROSPECTIVE CHD RISK FACTORS IN THE FRAMINGHAM
STUDY
E.J.Schaefer, USA |
| 13:00-14:00 |
Lunch Break, Exhibition and Poster Viewing |
| 14:00-15:00 |
Auditorium (Anitschkow Hall) |
| ALTAN ONAT LECTURE
|
| Chair: |
Ç. Erol, Turkey |
TBA
R. Mahley, USA |
| YOUNG INVESTIGATORS AWARDS |
| Chairs: |
N. Koylan, Turkey
B. Staels, France |
| 2 x 15 min oral presentations |
| 15:00-15:45 |
Coffee Break, Exhibition and Poster Viewing |
| 14:00-15:00 |
Marmara (Michael Davies) |
| Debate |
MEDICAL TREATMENT IS THE ONLY TREATMENT OF ATHEROSCLEROSIS VS.
INTERVENTION OF ATHEROSCLEROSIS IS HERE TO STAY |
| Chair: |
M. Bots, The Netherlands |
TREATMENT
C. Ballantyne, USA |
INTERVENTION
P. Widimsky, Czech Republic |
| 15:00-15:45 |
Coffee Break, Exhibition and Poster Viewing |
| 14:00-15:00 |
Topkapi (Remzi Özcan) |
| Meet the Experts |
| PREDICTIVE AND PROTECTIVE AUTOIMMUNITY IN CARDIOVASCULAR DISEASES: IS
VACCINATION THERAPY A REALITY? |
| Chairs: |
J. Nilsson, Sweden
P.K.Shah, USA |
| 15:00-15:45 |
Coffee Break, Exhibition and Poster Viewing |
| 14:00-15:00 |
Haliç (Nikkila) |
| Meet the Experts |
| NEW PARADIGMS ON HYPERTENSION TREATMENT |
| Chairs: |
L.M.Ruilope, Spain
R .Cifková, Czech Republic |
| 15:00-15:45 |
Coffee Break, Exhibition and Poster Viewing |
| 15:45-17:15 |
Auditorium (Anitschkow Hall) |
| Workshop |
| THE ROLE OF LIFESTYLE MODIFICATION, NUTRITION AND EXERCISE IN CHD
PREVENTIO |
| Chairs: |
A. Zampelas, Greece
R. Ross, Canada |
TBA
R. Ross, Canada |
THE ROLE OF DIETARY MODIFICATION IN CHD PREVENTION
A. Zampelas, Greece |
FORTIFICATION OF ATHEROGENIC DIET WITH CRANBERRY EXTRACT AND SPINACH:
PLASMA LDL OXIDATION AND OTHER ATHEROSCLEROSIS RISK FACTORS IN RATS
S. Ghazala, Canada |
PREDICTED RISK IS REDUCED BY AN INTERVENTION PROGRAM TO
EVALUATE/COMMUNICATE 10-YEAR CHD RISK VERSUS USUAL CARE: THE REACH
OUT STUDY
L. Erhardt, Sweden |
ASSOCIATIONS AMONG FATTY ACIDS IN RED BLOOD CELLS AND COMPONENTS OF
THE METABOLIC SYNDROME
M. E. Tejero, USA |
CARDIOPROTECTIVE EFFECT OF RESVERATROL
A. Novakovic, Serbia |
| 17:15-17:30 |
Break |
| 15:45-17:15 |
Marmara (Michael Davies) |
| Workshop |
| NOVEL THERAPIES FOR PREVENTING CVD |
| Chairs: |
M. Azizi, France
M. Navab, USA |
BLOCKADE OF THE RENIN ANGIOTENSINS SYSTEM WITH RENIN INHIBITORS
M. Azizi, France |
TBA
M. Navab, USA |
A TWO-YEAR STUDY TO ASSESS THE EFFICACY, SAFETY, AND TOLERABILITY OF
TARANABANT IN OBESE PATIENTS: 52 WEEK RESULTS
R. Carr, Denmark |
THE CARDIOVASCULAR SAFETY OF THE CHOLESTERYL ESTER TRANSFER PROTEIN
(CETP) INHIBITOR, R1658/JTT-705: PHASE II FINDINGS
E.S.G. Stroes, The Netherlands |
PHARMACOLOGICAL BLOCKADE OF CCR2 INHIBITS THE DEVELOPMENT OF INSULIN
RESISTANCE AND HEPATIC STEATOSIS IN DB/DB MICE
Y. Tamura, Japan |
BLOCKADE OF THE ANGIOTENSIN TYPE 2 (AT2) RECEPTOR DECREASES DIABETESASSOCIATED
ATHEROSCLEROSIS
A. Koitka, Australia |
| 17:15-17:30 |
Break |
| 15:45-17:15 |
Topkapi (Remzi Özcan) |
| Workshop |
| CELLULAR UPTAKE AND STORAGE OF LIPIDS |
| Chairs: |
C. Londos, USA
T. van Berkel, The Netherlands |
TBA
C. Londos, USA |
LIPID HOMEOSTASIS IN MACROPHAGES AND ATHEROSCLEROSIS
T. van Berkel, The Netherlands |
A NEW HYPOTHESIS OF LIPID DROPLET BIOGENESIS
H. Robenek, Germany |
INFLAMMATION CAUSES STATIN RESISTANCE: A POTENTIAL MECHANISM FOR
INEFFECTIVENESS OF STATIN THERAPY
X. Ruan, UK |
NON-INVASIVE IN VIVO IMAGING OF RECOMBINANT POSTPRANDIAL LIPOPROTEINS
LABELLED WITH NANOCRYSTALS
O. Bruns, Germany |
MECHANISMS OF ACUTE ISCHEMIA-DEPENDENT MYOCARDIAL LIPID
ACCUMULATION:
A NOVEL ROLE FOR THE VERY-LOW-DENSITY-LIPOPROTEIN
RECEPTOR
J. Perman, Sweden |
| 17:15-17:30 |
Break |
| 15:45-17:15 |
Haliç (Nikkila) |
| Workshop |
| CHEMOKINE AND INNATE RECEPTORS IN VASCULAR DISEASE |
| Chairs: |
D.R. Greaves, UK
C. Weber, Germany |
THE CONTRIBUTION OF CHEMOKINES AND OTHER INFLAMMATORY MEDIATORS TO
ATHEROSCLEROSIS
D.R. Greaves, UK |
TBA
C. Weber, Germany |
NEUTROPHIL RECRUITMENT IN MURAL THROMBUS OF HUMAN ABDOMINAL AORTIC
ANEURYSM
X. Houard, France |
FREE HEMOGLOBIN:A CHEMOTACTIC STIMULUS FOR THE INNATE IMMUNITY
B. Buttari, Italy |
A NOVEL ROLE FOR IGF2/IGF2R SIGNALING IN HOMING OF ENDOTHELIAL
PROGENITOR CELLS
Y-G.Kwon, South Korea |
ENHANCED NEUTROPHIL EXPRESSION OF ANNEXIN-1 IN CORONARY ARTERY
DISEASE
E. Sarndahl, Sweden |
| 17:15-17:30 |
Break |
| 17:30-19:00 |
MERCK & CO SPONSORED SYMPOSIUM
THE BRIDGE TO ACHIEVING THE GREATER LDL-C GOAL OF <70 MG/DL: INHIBITING
CHOLESTEROL ABSORPTION AND PRODUCTION |
| 17:30-19:00 |
UNILEVER SPONSORED SYMPOSIUM |
| 17:30-19:00 |
GENZYME CARDIOVASCULAR SPONSORED SYMPOSIUM |
| 17:30-19:00 |
Dolmabahçe (Overflow Eisenberg Hall) |
| EAS MEMBERS GENERAL ASSEMBLY |
| |
| TUESDAY APRIL 29, 2008 |
| 08:30-10:30 |
Auditorium (Anitschkow Hall) |
| ADIPOTOXICITY AND VASCULAR DISEASE |
| Chairs: |
C. Ehnholm, Finland
R. Zechner, Austria |
ADIPOTOXICITY AND THE INSULIN RESISTANCE SYNDROME
G. Shulman, USA |
ADIPOSITY, INFLAMMATION AND THE HEART
A. M. Sharma, Canada |
METABOLOMICS, A NOVEL TOOL FOR UNDERSTANDING LIPID DYSFUNCTION AND
RELATED DISORDERS
M. Oresic, Finland |
THE ENDOCANNABINOID SYSTEM AND CARDIOVASCULAR RISK: PATHOPHYSIOLOGIC
ROLE AND THERAPEUTIC INTERVENTIONS
V. Di Marzo, Italy |
| 10:30-11:30 |
Coffee Break, Exhibition and Poster Viewing |
| 11:30-13:00 |
Auditorium (Anitschkow Hall) |
| LATE BREAKING SESSION |
| Chairs: |
O. Ergene, Turkey
O. Wiklund, Sweden |
| 11:30-13:00 |
Marmara (Michael Davies) |
| Workshop |
| INSULIN RESISTANCE AND HYPERLIPIDEMIA IN CHD |
| Chairs: |
L.M. Havekes, The Netherlands
M-R. Taskinen, Finland |
FATTY ACID METABOLISM IS KEY PLAYER IN THE METABOLIC RELATIONSHIP
BETWEEN INSULIN RESISTANCE AND HYPERLIPIDEMIA
L.M. Havekes, The Netherlands |
TBA
M-R. Taskinen, Finland |
DOSE-DEPENDENT EFFECT OF ROSUVASTATIN ON PLASMA APOLIPOPROTEIN C-III
KINETICS IN MEN WITH THE METABOLIC SYNDROME
E. Ooi, Australia |
NON-FASTING TRIGLYCERIDES AND RISK OF ISCHEMIC STROKE IN THE GENERAL
POPULATION
B.G. Nordestgaard, Denmark |
EFFICACY AND SAFETY OF EZETIMIBE/SIMVASTATIN COADMINISTERED WITH
EXTENDED RELEASE NIACIN IN PATIENTS WITH TYPE IIA OR IIB HYPERLIPIDEMIA
S. Fazio, USA |
DECREASED CETP AND LPL ACTIVITIES MAY CONTRIBUTE TO ATHEROGENIC
DYSLIPIDEMIA IN HIV INFECTED PATIENTS RECEIVING PROTEASE INHIBITOR
THERAPY
P. Benlian, France |
| 11:30-13:00 |
Topkapi (Remzi Özcan) |
| Workshop |
TREATMENT OF ISCHAEMIC HEART DISEASE AND ACUTE CORONARY
SYNDROMES |
| Chairs: |
J.W. Jukema, The Netherlands
Z.Öngen, Turkey |
THE GOALS OF PLATELET INHIBITION IN ACUTE CORONARY SYNDROME PATIENTS
J.W. Jukema, The Netherlands |
TBA
Z.Öngen, Turkey |
EFFECTS OF TIROFIBAN ON ANGIOGRAPHIC MEASURES, ST RESOLUTION, AND
CLINICAL OUTCOME FOLLOWING THE PRIMARY CORONARY INTERVENTION IN
PATIENTS WITH STEMI
N. Keles, Turkey |
RECONSTITUTED HDL THERAPY FOR CARDIOVASCULAR DISEASE
S.I. Miura, Japan |
HYPERTRIGLYCERIDEMIA, CARDIOVASCULAR RISK FACTORS, AND GLOBAL
CARDIOVASCULAR RISK IN THE SPANISH WORKING POPULATION. ICARIA STUDY
GROUP
V. F. Pedro, Spain |
| TBA |
| 11:30-13:00 |
Haliç (Nikkila) |
| EUROPEAN NETWORK OF INHERITED DYSLIPIDAEMIAS (ENID) |
| Chairs: |
O. Descamps, Belgium
J.A. Kuivenhoven, The Netherlands |
TBA
T.P. Bersot, USA |
TBA
N. Unaltuna, Turkey |
| 13:00-14:30 |
Auditorium (Anitschkow Hall) |
| ANITSCHKOW AWARD LECTURE |
| Chair: |
M-R. Taskinen, Finland |
| TBA |
CLOSING CEREMONY
CONGRESS CHAIRPERSON
L. Tokgözoglu, Turkey |
